Nyumbani › Saratani ya Matiti › Texas › Abilene
Majaribio ya kliniki ya Saratani ya Matiti katika Abilene, TX
Masomo 5 ya Saratani ya Matiti yanatafuta washiriki katika vituo vya Abilene na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
InaajiriHatua 3
- Hendrick Medical Center ( Site 0009), Abilene
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
InaajiriHatua 3
- Hendrick Medical Center, Abilene
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
InaajiriHatua 3
- Hendrick Cancer Center, Abilene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
InaajiriHatua 1/2
- USOR Texas Oncology, Abilene
Evaluation of the Bexa Breast Examination
InaajiriWajitolea wenye afya wanakaribishwa
- Hendrick Health - Vera West Women's Center, Abilene
Majaribio ya Saratani ya Matiti katika miji mingine
- New York City, NYUtafiti 134
- Houston, TXUtafiti 126
- Boston, MAUtafiti 111
- Nashville, TNUtafiti 80
- Los Angeles, CAUtafiti 72
- Edison, NJUtafiti 68
- St. Louis, MOUtafiti 64
- Durham, NCUtafiti 63
- Queens, NYUtafiti 63
- Chicago, ILUtafiti 58
- Philadelphia, PAUtafiti 56
- Dallas, TXUtafiti 55
Masomo mengine katika Abilene
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 8
- Saratani ya MetastasiUtafiti 5
- Kansari ya kolorektaliUtafiti 5
- Kansari ya MayaiUtafiti 4
- Uharibifu wa MakulaUtafiti 4
- Saratani ya Matiti ya Triple-NegativeUtafiti 3
- Atrofi ya KijiografiaUtafiti 3
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.